Annual FCF:
-$307.94M-$184.64M(-149.76%)Summary
- As of today, RNA annual free cash flow is -$307.94 million, with the most recent change of -$184.64 million (-149.76%) on December 31, 2024.
- During the last 3 years, RNA annual free cash flow has fallen by -$209.38 million (-212.46%).
- RNA annual free cash flow is now -13755.70% below its all-time high of $2.25 million, reached on December 31, 2019.
Performance
RNA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$156.88M+$46.12M(+22.72%)Summary
- As of today, RNA quarterly free cash flow is -$156.88 million, with the most recent change of +$46.12 million (+22.72%) on September 30, 2025.
- Over the past year, RNA quarterly free cash flow has dropped by -$89.57 million (-133.05%).
- RNA quarterly free cash flow is now -1103.23% below its all-time high of $15.64 million, reached on December 31, 2023.
Performance
RNA Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$592.26M-$89.57M(-17.82%)Summary
- As of today, RNA TTM free cash flow is -$592.26 million, with the most recent change of -$89.57 million (-17.82%) on September 30, 2025.
- Over the past year, RNA TTM free cash flow has dropped by -$403.75 million (-214.18%).
- RNA TTM free cash flow is now -4565.19% below its all-time high of $13.26 million, reached on June 30, 2019.
Performance
RNA TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
RNA Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -149.8% | -133.1% | -214.2% |
| 3Y3 Years | -212.5% | -392.5% | -366.7% |
| 5Y5 Years | -10000.0% | -1475.5% | -2278.7% |
RNA Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -212.5% | at low | -1103.2% | +22.7% | -380.4% | at low |
| 5Y | 5-Year | >-9999.0% | at low | -1103.2% | +22.7% | -2278.7% | at low |
| All-Time | All-Time | >-9999.0% | at low | -1103.2% | +22.7% | -4565.2% | at low |
RNA Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$156.88M(+22.7%) | -$592.26M(-17.8%) |
| Jun 2025 | - | -$203.01M(-57.9%) | -$502.70M(-37.6%) |
| Mar 2025 | - | -$128.58M(-23.9%) | -$365.22M(-18.6%) |
| Dec 2024 | -$307.94M(-149.8%) | -$103.79M(-54.2%) | -$307.94M(-63.4%) |
| Sep 2024 | - | -$67.32M(-2.7%) | -$188.51M(-18.6%) |
| Jun 2024 | - | -$65.53M(+8.1%) | -$158.91M(-10.5%) |
| Mar 2024 | - | -$71.30M(-555.9%) | -$143.80M(-16.6%) |
| Dec 2023 | -$123.29M(+11.4%) | $15.64M(+141.5%) | -$123.29M(+31.1%) |
| Sep 2023 | - | -$37.71M(+25.2%) | -$178.97M(-3.4%) |
| Jun 2023 | - | -$50.43M(+0.7%) | -$173.11M(-8.5%) |
| Mar 2023 | - | -$50.79M(-26.8%) | -$159.55M(-14.7%) |
| Dec 2022 | -$139.09M | -$40.04M(-25.7%) | -$139.09M(-9.6%) |
| Sep 2022 | - | -$31.85M(+13.6%) | -$126.90M(-8.7%) |
| Jun 2022 | - | -$36.87M(-21.5%) | -$116.69M(-7.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$30.33M(-8.9%) | -$108.68M(-10.3%) |
| Dec 2021 | -$98.55M(-157.9%) | -$27.85M(-28.7%) | -$98.55M(-17.3%) |
| Sep 2021 | - | -$21.64M(+25.0%) | -$84.01M(-16.2%) |
| Jun 2021 | - | -$28.85M(-42.8%) | -$72.33M(-41.6%) |
| Mar 2021 | - | -$20.21M(-51.8%) | -$51.07M(-33.7%) |
| Dec 2020 | -$38.21M(-1794.4%) | -$13.31M(-33.7%) | -$38.21M(-53.5%) |
| Sep 2020 | - | -$9.96M(-31.1%) | -$24.90M(-19.5%) |
| Jun 2020 | - | -$7.60M(-3.5%) | -$20.84M(-1088.6%) |
| Mar 2020 | - | -$7.34M(-24.5%) | $2.11M(-71.4%) |
| Dec 2019 | $2.25M(+123.2%) | - | - |
| Sep 2019 | - | -$5.90M(-138.4%) | $7.37M(-44.5%) |
| Jun 2019 | - | $15.35M(+835.9%) | $13.26M(+735.9%) |
| Mar 2019 | - | -$2.09M | -$2.09M |
| Dec 2018 | -$9.70M | - | - |
FAQ
- What is Avidity Biosciences, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. annual free cash flow year-on-year change?
- What is Avidity Biosciences, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. quarterly free cash flow year-on-year change?
- What is Avidity Biosciences, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. TTM free cash flow year-on-year change?
What is Avidity Biosciences, Inc. annual free cash flow?
The current annual free cash flow of RNA is -$307.94M
What is the all-time high annual free cash flow for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high annual free cash flow is $2.25M
What is Avidity Biosciences, Inc. annual free cash flow year-on-year change?
Over the past year, RNA annual free cash flow has changed by -$184.64M (-149.76%)
What is Avidity Biosciences, Inc. quarterly free cash flow?
The current quarterly free cash flow of RNA is -$156.88M
What is the all-time high quarterly free cash flow for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high quarterly free cash flow is $15.64M
What is Avidity Biosciences, Inc. quarterly free cash flow year-on-year change?
Over the past year, RNA quarterly free cash flow has changed by -$89.57M (-133.05%)
What is Avidity Biosciences, Inc. TTM free cash flow?
The current TTM free cash flow of RNA is -$592.26M
What is the all-time high TTM free cash flow for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high TTM free cash flow is $13.26M
What is Avidity Biosciences, Inc. TTM free cash flow year-on-year change?
Over the past year, RNA TTM free cash flow has changed by -$403.75M (-214.18%)